Search

everythinglearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A new method accurately measures a drug in skin for cancer therapy research.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The new composite scaffold may effectively treat chronic and deep wounds.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A certain surfactant sticks to human hair, making it change from water-repelling to water-attracting, which could help in hair conditioning.

PLD is an effective and safer alternative for treating breast cancer.

Precision neuromodulation may improve schizophrenia symptoms.

Point of Care in radiology speeds up diagnosis and treatment by performing tests where the patient is.

Decorin helps hair growth by influencing specific cell signals.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

A new method improves platelet testing for heart disease patients.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Dermal papilla cell-conditioned medium can help reduce skin aging caused by oxidative stress.

Finasteride is advertised directly to consumers for treating male pattern hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

Using Mark Cuban Cost Plus Drug Company can save money on men's health medications compared to Medicare.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

The diphosphonate was the most effective at preventing calcification in rats.